Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

GSK is delivering consistent financial performance ... as we plan to make further investments to drive future supply chain efficiencies, with additional charges of around GBP100 million.

chain structures, segmentation and sub-segments so on. It highlights various modifications held in the market to improve the market growth. The market report reviews the effect of demand, supply, ...

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...

The big pharma company GlaxoSmithKline will inject up to $800 million into its manufacturing site in Marietta, Pennsylvania, ...

Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

President Global Supply Chain, GSK said. “We’re grateful for the support of local and state officials, who made this project possible, and we are excited to expand upon the important work ...

The FTSE 100 index is set to remain under pressure, having fallen by 0.8% in yesterday’s session. Futures trading is pointing ...

The Clorox Company (NYSE: CLX) announced a strategic partnership with Manufacture 2030, or M2030, to help Clorox's suppliers ...

GSK topped the fallers board ... The Warwickshire-based firm last month scaled back estimates for 2024 due to supply chain disruption and weak demand in China. Volumes rose 14% to 1641 in the ...

GSK, meanwhile, has also completed another ... but proved particularly tough on the supply chains relied on to support public health. Discover how AI is transforming the pharma commercial strategy.